
The Securities and Exchange Board of India (SEBI) is probing alleged misuse of funds raised through nearly 20 SME IPOs managed by First Overseas Capital Ltd (FOCL), revealing diversions amounting to as much as ₹100 crore, as per the news reports. Funds intended for growth were reportedly transferred to promoter-linked entities and vendors without genuine operations.
SEBI’s ongoing investigation suggests a pattern of fund diversion from IPO proceeds in issues managed by FOCL. Companies under scrutiny include Sameera Agro and Infra, QMS Medical Allied Services, Amanaya Ventures, and Italian Edibles, among others. Forensic reviews of bank accounts and vendor payments indicated that IPO funds, raised for business purposes, were instead sent to connected entities without clear business justification.
The modus operandi reportedly involves transferring funds within weeks of listing, often under the guise of vendor payments or upfront advances. In the case of Nirman Agri Genetics, as much as ₹18.89 crore, 93% of the raised amount was found misutilised soon after the IPO. Similarly, Synoptics Technologies allegedly transferred nearly ₹19 crore just before listing, stating them as issue-related costs.
The 20 SME IPOs collectively raised about ₹560 crore over the past 3 years. SEBI is now evaluating whether similar diversion methods were employed across IPOs from Cell Point (India), On Door Concepts, Ducol Organics & Colours, Ishan International and others. Orders on these probes are expected in the coming months.
Although SEBI passed final orders last month penalising FOCL for procedural breaches, including underwriting and disclosure lapses, the current diversion-focused investigation runs independently. The scope includes deeper scrutiny into escrow flows, promoter-beneficiary links and fund disbursal timelines.
Read More: SEBI Urges Digital Platforms to Tackle Fraudulent Investment Activities!
SEBI’s unfolding probe into FOCL-managed SME IPOs highlights significant concerns about the misuse of investor funds. With potential diversions of up to ₹100 crore, further regulatory actions are anticipated as more cases of fund redirection emerge across listings.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Nov 10, 2025, 3:20 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates